ICER's mission is to lead innovation in comparative effectiveness research through methods that integrate considerations of clinical benefit and economic value. Through a unique collaboration with patients, clinicians, manufacturers, insurers and other healthcare stakeholders, ICER develops tools to support patient decisions and medical policy that share the goal of achieving maximum value for every healthcare dollar.
| ICER analyzes newly-published prostate cancer evidence |
|
ICER has published an analysis of recently-published research on the effectiveness and harms associated with minimally-invasive vs. traditional open radical prostatectomy entitled "Active Surveillance/Radical Prostatectomy: Analysis of New Evidence". |